Hill-Rom Holdings, Inc. (HRC) |
| 155.96 0.05 (0.03%) 04-24 15:47 |
| Open: | 155.89 |
| High: | 155.99 |
| Low: | 155.86 |
| Volume: | 566,404 |
| Market Cap: | 0(M) |
| PE Ratio: | 41.92 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Instruments & Supplies |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 27.74 |
| Resistance 1: | 23.75 |
| Pivot price: | 22.55 |
| Support 1: | 21.93 |
| Support 2: | 20.80 |
| 52w High: | 156.22 |
| 52w Low: | 93.34 |
Hill-Rom Holdings, Inc. functions as a global enterprise specializing in medical technology, structured into three primary operational areas: Patient Support Systems, Front Line Care, and Surgical Solutions. The Patient Support Systems division provides a variety of essential equipment, including medical-surgical, intensive care unit, and bariatric patient beds, alongside patient lifts and related devices, non-invasive therapeutic surfaces, and cutting-edge information technology and software. This segment also offers service contracts for its capital equipment. Under its Front Line Care offerings, the company furnishes comprehensive patient monitoring and diagnostic instruments. These encompass general patient examination and diagnostic tools, continuous patient monitoring systems, diagnostic cardiology products, and vision screening devices. Additionally, it supplies a suite of respiratory health products, such as the Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000, all designed to facilitate the mobilization of retained blockages in patients. The Surgical Solutions segment delivers critical operating room infrastructure, including surgical tables, specialized lighting, and ceiling-mounted pendants. It also manufactures precision positioning devices for various procedures like shoulder, hip, spinal, and lithotomy surgeries, along with universal positioning accessories compatible with diverse operating room tables. Hill-Rom's products and services reach a broad spectrum of healthcare providers. They are distributed and leased directly to acute and extended care facilities through its dedicated sales force and various distributors. The company also sells and rents directly to individual patients for home use and supplies primary care facilities via distribution partners. Its comprehensive clinical offerings cater to acute care, primary care, and even clinical research organizations. Established in 1969, Hill-Rom Holdings, Inc. maintains its headquarters in Chicago, Illinois.
| EPS | -1.960 |
| Book Value | 29.670 |
| PEG Ratio | 0.51 |
| Gross Profit | 5.421 |
| Profit Margin (%) | -6.92 |
| Operating Margin (%) | -1.68 |
| Return on Assets (ttm) | -2.0 |
| Return on Equity (ttm) | -6.4 |
Sat, 14 Dec 2024
Hill-Rom Holdings (NYSE:HRC) - intelligentinvestor.com.au
Tue, 01 Nov 2022
John P Groetelaars Net Worth (2026) - GuruFocus
Sun, 29 Aug 2021
Baxter is in advanced talks to buy Hill-Rom for about $10B - Fox Business
Tue, 19 Jan 2021
Hillrom Announces Planned Acquisition Of Bardy Diagnostics, Inc. - PR Newswire
Tue, 01 Dec 2020
Hill-rom Holdings Stock Price Forecast. Should You Buy HRC? - StockInvest.us
Wed, 10 Jul 2019
Hillrom Announces Sale Of Surgical Consumable Products - PR Newswire
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |